EYEGENE

eyegene-logo

EyeGene is biopharmaceutical Company.

#SimilarOrganizations #Website #More

EYEGENE

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2000-06-23

Address:
Seoul, Seoul-t'ukpyolsi, South Korea

Country:
South Korea

Website Url:
http://www.eyegene.co.kr

Total Employee:
51+

Status:
Active

Contact:
82 2 322 1687

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Content Delivery Network Font Awesome Apache Mobile Non Scaleable Content JsDelivr


Similar Organizations

aposcience-ag-logo

Aposcience AG

Aposcience AG is a biopharmaceutical company.

xanthus-pharmaceuticals-logo

Xanthus Pharmaceuticals

Xanthus is a biopharmaceutical company.

Official Site Inspections

http://www.eyegene.co.kr Semrush global rank: 4.77 M Semrush visits lastest month: 1.94 K

  • Host name: 211.47.74.55
  • IP address: 211.47.74.55
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "EyeGene"

EYEGENE Inc.

ABOUT EYEGENE. Clinical stage biopharmaceutical developing vaccines and new innovative recombinant protein drugs. EyeGene took its first step in the development of innovative biopharmaceutical drugs when it was first โ€ฆSee details»

Wonil Yoo๋‹˜ - CEO - EyeGene, inc. | LinkedIn

CEO at EyeGene, Inc. · ABOUT EYEGENE Clinical stage biopharmaceutical developing vaccines and new innovative recombinant protein drugs EyeGene โ€ฆSee details»

EYEGENE Inc. Company Profile | Seoul, Seoul, Republic Of Korea ...

Find company research, competitor information, contact details & financial data for EYEGENE Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»

EyeGene - Crunchbase Investor Profile & Investments

Eyegene.co.kr ; 42,146; Highlights. Investments 1. Investors 1. Similar Companies 5. ... Legal Name EyeGene Inc. Company Type For Profit; Phone Number 82 2 322 1687; Lists Featuring โ€ฆSee details»

EyeGene, Inc. Company Profile - South Korea | Financials & Key

Jul 5, 2024 EyeGene, Inc. is a company located in Seoul, South Korea. It was established in June 2000 as Igene Co., Ltd. and focuses on bio-drug development to address the challenges โ€ฆSee details»

EyeGene, Inc. - BIO International Convention | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... EyeGene, Inc. Booth 2464. โ€ฆSee details»

EYEGENE Inc.

EyeGene has established a network through strong alliances with University Hospitals. Further networks have been established with Yonsei Universityโ€™s proteomics research laboratory, Yonsei University Medical Centerโ€™s โ€ฆSee details»

EyeGene (KOSDAQ:185490) Company Profile & Description

Apr 15, 2025 Company profile for EyeGene Inc. (KOSDAQ:185490) with a description, list of executives, contact details and other key facts.See details»

EyeGene, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Www.eyegene.co.kr. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The statistics for โ€ฆSee details»

EYEGENE.Inc Annual Report - englishdart.fss.or.kr

[email protected]: Disclosure Contact: SH, Chai: Deputy General Manager: 02-322-1687: 02-302-4359: [email protected]: Form Information. Consolidated Financial โ€ฆSee details»

Eyegene - Overview, News & Similar companies | ZoomInfo.com

Oct 4, 2021 Eyegene contact info: Phone number: +82 23221687 Website: www.eyegene.co.kr What does Eyegene do? EyeGene took its first step in the development of innovative โ€ฆSee details»

EyeGene Inc. Company & People | 185490 - Barron's

EyeGene Inc. company and executive profile by Barron's. View the latest 185490 company infomation and executive bios. ... Shanghai Hile Bio-Technology Co. Ltd. A. 2.27 % ¥4.74B. โ€ฆSee details»

EYEGENE Inc.

๊ถŒ์„ ์ข… ์•„์ด์ง„ ์—ฐ๊ตฌ์†Œ์žฅ โ€œํ•œ๊ตญํŒ ๋ชจ๋”๋‚˜ ํƒ„์ƒ ์ฃผ๋„ํ•  ๊ฒƒโ€ [ 2024๋…„ 11์›” 11์ผ - ์ด๋ฐ์ผ๋ฆฌ ] ์•„์ด์ง„ ์ฃผ์‹ํšŒ์‚ฌ์˜ ๊ถŒ์„ ์ข… ๋ฐ•์‚ฌ๋Š” ์ง€๋‚œ 9์›”, ์—ฐ๊ตฌ์†Œ์žฅ์— ์„ ์ž„๋˜์—ˆ์œผ๋ฉฐ ์•ž์œผ๋กœ ์ œ2์˜ ํŒฌ๋ฐ๋ฏน์— ๋Œ€๋น„ํ•œ โ€ฆSee details»

EyeGene initiates strategic R&D overhaul with BMI Korea โ€ฆ

Dec 14, 2023 EyeGene, a messenger ribonucleic acid (mRNA) vaccine developer, has ushered in BMI Korea as its new largest shareholder.The company is drawing attention by announcing โ€ฆSee details»

EuBiologics license out EuMCV4 meningococcal vaccine to โ€ฆ

Jul 3, 2024 Eyegene is a Korean biotech firm developing vaccines against shingles, tuberculosis, and Covid-19 using its own adjuvant platform technology. The agreement follows EuBiologics' โ€ฆSee details»

Kukje, Eyegene to co-develop non-proliferative diabetic ... - KBR

Jun 12, 2023 Kukje Pharm said Monday that it has signed an agreement with Eyegene to co-develop EG-Mirotin, the world's first treatment for non-proliferative diabetic retinopathy. โ€ฆSee details»

EYEGENE Inc.

T. +82-2-322-1687 f. +82-2-302-4359 / +82-2-324-8059 ๋ณธ์‚ฌ : [16009] ๊ฒฝ๊ธฐ๋„ ์˜์™•์‹œ ์–‘์ง€ํŽธ2๋กœ 13, 2์ธต (์ฒญ๊ณ„๋™, ํ•œ๊ตญ๋น„์— ์•„์ด ๋นŒ๋”ฉ) ์—ฐ๊ตฌ์†Œ : [16009] ๊ฒฝ๊ธฐ๋„ ์˜์™•์‹œ ์–‘์ง€ํŽธ2๋กœ 7, 4์ธต (์ฒญ๊ณ„๋™, โ€ฆSee details»

EyeGene-EyeGene Inc.-ไผไธš่ฏฆๆƒ…-InvestGOๆ•ฐๆฎๅบ“-ByDrug-ๅŒป่ฏ้ญ” โ€ฆ

Dec 31, 1999 ๆŸฅ็œ‹ๅŒป่ฏ้ญ”ๆ–นInvestGO®ๆ•ฐๆฎๅบ“EyeGene็š„ๅ…ฌๅธไฟกๆฏใ€‚EyeGene๏ผˆEyeGene Inc.๏ผ‰๏ผŒๅ…ฌๅธ็ฎ€ไป‹๏ผšEyeGene, Inc. is a Korean Proteomics & Biopharmaceutical Bio-Venture โ€ฆSee details»

EYEGENE Inc.

Established EyeGene, Inc. T. +82-2-322-1687; F. +82-2-302-4359 / +82-2-324-8059; ๋ณธ์‚ฌ : [16009] ๊ฒฝ๊ธฐ๋„ ์˜์™•์‹œ ์–‘์ง€ํŽธ2๋กœ 13, 2์ธต (์ฒญ๊ณ„๋™, ํ•œ๊ตญ๋น„์— ์•„์ด ๋นŒ๋”ฉ) ์—ฐ๊ตฌ์†Œ : [16009] ๊ฒฝ๊ธฐ๋„ โ€ฆSee details»

EYEGENE Inc.

EyeGene R&D Center was officially authorized in May 2001 and has been dedicated to developing innovative biopharmaceuticals, vaccines, and diagnostic system for the treatment โ€ฆSee details»

linkstock.net © 2022. All rights reserved